Neurobit uses sleep as a biomarker across age, gender and race to predict and prevent adverse health outcomes well before they happen.
Founded in 2018 by Amiya and Kishan, Neurobit has a visionary mission to revolutionize healthcare and increase accessibility. Annually, over 26 million people suffer from heart failure, 15 million experience strokes, and 10 million develop dementia. Neurobit utilizes physiological signals gathered during sleep to identify predictive patterns. Their state-of-the-art AI models, trained on a trillion data points of multi-channel physiological data, form a Universal health analytics platform. Neurobit's technologies are already employed by 120+ universities, hospitals, and research centers worldwide. They are driving the future of healthcare with data-driven innovation.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 1, 2020 | Grant | — | 1 | — | — | Detail |
Jan 30, 2020 | Grant | — | 1 | — | — | Detail |
Jan 30, 2020 | Convertable Note | S$300K | — | — | — | Detail |
Jan 1, 2019 | Convertable Note | — | — | — | — | Detail |
Jul 17, 2018 | Pre-seed | S$107K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
iHealthtech ,NUS | — | Grant |
Enterprise Singapore | — | Grant |
Entrepreneur First | — | Pre-seed |